{"id":4779,"date":"2025-04-30T09:17:19","date_gmt":"2025-04-29T23:17:19","guid":{"rendered":"\/americas\/?p=4779"},"modified":"2026-03-03T15:03:33","modified_gmt":"2026-03-03T05:03:33","slug":"orthocell-secures-health-canada-approval-for-remplir-in-us75-million-canadian-market","status":"publish","type":"post","link":"\/americas\/orthocell-secures-health-canada-approval-for-remplir-in-us75-million-canadian-market\/","title":{"rendered":"Orthocell Secures Health Canada Approval for Remplir\u2122 in US$75 million Canadian Market"},"content":{"rendered":"<p>Orthocell has secured a Medical Device Licence from Health Canada for Remplir\u2122, opening access to the US$75 million Canadian nerve repair market.<\/p>\n<p>This approval comes earlier than expected following our February submission, highlighting the exceptional quality of our product and clinical data.<\/p>\n<p>Remplir\u2122 is now approved across six key markets \u2013 the US, Canada, Thailand, Australia, New Zealand, and Singapore \u2013 representing a combined market opportunity of $1.8 billion.<\/p>\n<p><strong>Orthocell CEO and MD, Paul Anderson, said:<\/strong><\/p>\n<p>\u201cWe are building a significant portfolio of jurisdictions in which Remplir is approved for sale, and we\u2019re delighted to add Canada to this growing list. Each new regulatory approval is an important addition to the overall value of our product portfolio and our Company.\u201d<\/p>\n<p><a href=\"https:\/\/bit.ly\/OCC-Canada-Approval\">Click to read the ASX release.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell has secured a Medical Device Licence from Health Canada for Remplir\u2122, opening access to the US$75 million Canadian nerve repair market.<\/p>\n","protected":false},"author":2,"featured_media":4783,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[21,2],"tags":[],"class_list":["post-4779","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-asx-announcements","category-company-news"],"aioseo_notices":[],"_links":{"self":[{"href":"\/americas\/wp-json\/wp\/v2\/posts\/4779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/americas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/americas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/comments?post=4779"}],"version-history":[{"count":1,"href":"\/americas\/wp-json\/wp\/v2\/posts\/4779\/revisions"}],"predecessor-version":[{"id":4780,"href":"\/americas\/wp-json\/wp\/v2\/posts\/4779\/revisions\/4780"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/media\/4783"}],"wp:attachment":[{"href":"\/americas\/wp-json\/wp\/v2\/media?parent=4779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/categories?post=4779"},{"taxonomy":"post_tag","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/tags?post=4779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}